Alto Neuroscience, Inc. (NYSE:ANRO) IPO
IPO
Priced at US$16.00 a share on Feb 1, 2024.
- Price
- US$16.00 a share
- Shares offered
- 8,040,000 shares of common stock
- Offering size
- US$128.6 million
- Underwriters' option
- Up to 1,206,000 more shares
- Underwriters
- Jefferies, TD Cowen, Stifel, William Blair, Baird · In the order on the cover
- Shares delivered
- On or about Feb 6, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 22, 2023 |
| Filed publicly | Jan 12, 2024 |
| Amended twice | Newest Jan 29, 2024 |
| Shares registered with an exchange | Jan 30, 2024 |
| Declared effective by the SEC | Feb 1, 2024 |
| Final prospectus, with the price | Feb 5, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 5, 2024 |
| EFFECT · Notice that a registration is effective | Feb 1, 2024 |
| S-1MEF · Registration of more shares for the same offering | Feb 1, 2024 |
| CERT · Exchange's certificate of listing | Jan 30, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 30, 2024 |
| CORRESP · Letter to the SEC | Jan 30, 2024 |
| CORRESP · Letter to the SEC | Jan 30, 2024 |
| S-1/A · Registration statement, amended | Jan 29, 2024 |
| S-1/A · Registration statement, amended | Jan 29, 2024 |
| CORRESP · Letter to the SEC | Jan 25, 2024 |
| CORRESP · Letter to the SEC | Jan 24, 2024 |
| UPLOAD · Letter from the SEC | Jan 23, 2024 |
| CORRESP · Letter to the SEC | Jan 19, 2024 |
| CORRESP · Letter to the SEC | Jan 12, 2024 |
| S-1 · Registration statement | Jan 12, 2024 |
| UPLOAD · Letter from the SEC | Jan 9, 2024 |
| DRSLTR · Letter to the SEC with a draft | Dec 28, 2023 |
| DRS/A · Draft registration statement, amended | Dec 28, 2023 |
| UPLOAD · Letter from the SEC | Dec 19, 2023 |
| DRS · Draft registration statement | Nov 22, 2023 |
From the cover of the final prospectus (424B4) filed Feb 5, 2024